| Financial Year |
March 31 2023 |
| Monetary Funds |
234,486,725.70 |
| Held-for-trading Financial Assets |
50,015,692.35 |
| Notes Receivable |
79,566,696.45 |
| Accounts Receivable |
427,851,932.38 |
| Advances to Suppliers |
3,343,569.26 |
| Other Receivables |
1,526,304.05 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
242,981,979.05 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
17,099,556.95 |
| Total Current Assets |
1,056,872,456.19 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
123,181,250.67 |
| Investment Properties |
212,135.30 |
| Fixed Assetes |
234,772,656.28 |
| Under-construction Projects |
17,495,720.25 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
6,620,743.91 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
7,420,886.35 |
| Deferred Income Tax Assets |
22,269,281.75 |
| Other Non-Current Assets |
3,570,582.69 |
| Sub-Total of Non-Current Assets |
853,290,472.69 |
| Total Assets |
1,910,162,928.88 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
94,770.73 |
| Notes Payable |
138,182,703.61 |
| Accounts Payable |
197,242,320.14 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
37,743,817.86 |
| Taxes Payable |
7,287,076.93 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,557,538.92 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
19,328,578.47 |
| Other Current Liabilities |
93,762.50 |
| Sub-Total of Current Liabilities |
413,054,720.07 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
49,027,609.10 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
125,621,066.15 |
| Total Liabilities |
538,675,786.22 |
| Paid-In Capital(Or Share Stock) |
198,886,750.00 |
| Capital Surplus |
261,347,539.49 |
| Surplus Reserve |
66,834,119.04 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
695,583,992.59 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,371,487,142.66 |
| Owner's Equity（Stockholder's Equity） |
1,371,487,142.66 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,910,162,928.88 |
